Digital therapeutics developer Click Therapeutics acquired Better Therapeutics to enhance its presence in cardiometabolic disorders with the FDA-authorized AspyreRx diabetes app.
This acquisition provides Click a springboard for drug and digital treatment pairings, expanding its successful hybrid model with existing programs like Clickotine and Rejoyn.
#click-therapeutics #better-therapeutics #cardiometabolic-disorders #fda-authorized-digital-therapeutic #acquisition
Collection
[
|
...
]